2001
Serum complement activation in congestive heart failure
Clark D, Cleman M, Pfau S, Rollins S, Ramahi T, Mayer C, Caulin-Glaser T, Daher E, Kosiborod M, Bell L, Setaro J. Serum complement activation in congestive heart failure. American Heart Journal 2001, 141: 684-690. PMID: 11275938, DOI: 10.1067/mhj.2001.113758.Peer-Reviewed Original ResearchConceptsCongestive heart failureSymptomatic heart failureC5b-9 levelsHeart failureClinical outcomesC5b-9Control patientsNew York Heart Association class IV symptomsComplement activationAge-matched control patientsClass IV symptomsCombined clinical outcomeAdverse clinical outcomesVentricular ejection fractionTerminal complement complex C5b-9Terminal complement activationComplement complex C5b-9Serum complement activationTerminal complement complexAdverse eventsCardiopulmonary bypassEjection fractionSerum levelsMyocardial injuryMyocardial infarction
1992
The Right Ventricle in Disorders Causing Pulmonary Venous Hypertension
Setaro J, Cleman M, Remetz M. The Right Ventricle in Disorders Causing Pulmonary Venous Hypertension. Cardiology Clinics 1992, 10: 165-183. PMID: 1739957, DOI: 10.1016/s0733-8651(18)30261-3.Peer-Reviewed Original ResearchConceptsPulmonary venous hypertensionRight ventricular functionRight ventricleVenous hypertensionVentricular functionLeft-sided heart lesionsLeft-sided heart failurePulmonary arterial hypertensionCharacteristic clinical findingsPulmonary arterial systemImportant prognostic informationObstructive originArterial hypertensionHeart failureHemodynamic adaptationClinical findingsHeart lesionsPulmonary veinsPrognostic informationInterventricular septumHypertensionChronic compensationLeft ventricleVentricleArterial system
1990
Myocardial dysfunction during percutaneous transluminal coronary angioplasty.
Cleman M, Wohlgelernter D, Cabin H, Remetz M, McConnell S, Jaffe C. Myocardial dysfunction during percutaneous transluminal coronary angioplasty. Circulation 1990, 81: iv14-9. PMID: 2306846.Peer-Reviewed Original ResearchConceptsPercutaneous transluminal coronary angioplastyTransluminal coronary angioplastyBalloon inflationCoronary angioplastyEjection fractionMyocardial dysfunctionBrief balloon inflationBalloon inflation timeRegional myocardial dysfunctionRegional contractile dysfunctionTwo-dimensional echocardiographyRegional wall motionHemodynamic consequencesIschemic periodElectrocardiographic changesCardiac outputContractile dysfunctionProcedural resultsCoronary arteryPTCA proceduresTemporary ischemiaEchocardiographic recordingsVentricular myocardiumVentricular volumeInflation time
1986
Prevention of ischemia during percutaneous transluminal coronary angioplasty by transcatheter infusion of oxygenated Fluosol DA 20%.
Cleman M, Jaffee C, Wohlgelernter D. Prevention of ischemia during percutaneous transluminal coronary angioplasty by transcatheter infusion of oxygenated Fluosol DA 20%. Circulation 1986, 74: 555-562. PMID: 2943533, DOI: 10.1161/01.cir.74.3.555.Peer-Reviewed Original ResearchConceptsPercutaneous transluminal coronary angioplastyFluosol-DA 20Regional left ventricular dysfunctionLeft ventricular dysfunctionTransluminal coronary angioplastyTranscatheter infusionBalloon inflationVentricular dysfunctionCoronary angioplastyCatheter balloon inflationLeft ventricular reserveSubsequent myocardial ischemiaCoronary blood flowLactate solutionPrevention of ischemiaLonger inflation timesTwo-dimensional echocardiographyRinger's lactate solutionRegional wall motionRegional contractionDilating catheterDistal infusionVentricular reserveIschemic riskIntracoronary infusion